HealtheRx Survey for Pulmonary Research Registry Recruitment

Asthma Clinical Trial

Official title:

HealtheRx Survey for Pulmonary Research Registry Recruitment

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02653066
• Other study ID #: 15-1282
• Status: Completed
• Phase: N/A
• Start date: December 2015
• Est. completion date: December 2019

Study information

• Verified date: April 2020
• Source: University of Chicago
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The purpose of this research is to study the utility of using the HealtheRx as a tool to recruit eligible patients into the Pulmonary Research Registry (PRR) (IRB 15543B) at the University of Chicago. HealtheRx is an example of a potential recruitment tool that has high reach in populations typically underrepresented in research studies, uses a high tech infrastructure that allows matching of research opportunities to patient characteristics, but that delivers information in a low-tech, patient-centered mode using the printed HealtheRx prescription.

Description:

1. Patients living in one of 16 zip codes of the South and West Sides of Chicago who present for care at one or more of 30 clinical sites receive a personalized HealtheRx prescription with programs and services in the community from their health care provider. The HealtheRx is printed and delivered to the patient at the end of the visit.

2. Patients age 18+ with a diagnosis of asthma and/or COPD will receive a HealtheRx with programs/services to help manage their condition, as well as an advertisement to participate in a phone survey.

3. Patients interested in completing the phone survey can call or text the Lindau Lab at the University of Chicago.

4. An experienced survey researcher will first read the consent script and if oral consent is received, continue with the phone survey (The survey includes items pertaining to program participants' receipt of the HealtheRx, use of community services provided on the HealtheRx, thoughts about participation in clinical research.

5. Participants who choose to complete the survey will receive a $10 check delivered via U.S. mail to their home address. Patients interested in joining the PRR will receive the PRR consent form with their $25 check.

6. Participants with interest in joining the PRR will also receive, via mail, a $5 bill as thanks for reading, signing and returning the consent form. Participants will be randomized to receive the $5 bill at 2 different time points.

7. Once the signed consent form is received, a member of the Asthma and COPD Center research staff will contact the participant by phone and complete the PRR case report form by phone.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 41
• Est. completion date: December 2019
• Est. primary completion date: April 25, 2017
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• diagnosis of asthma/COPD

• receipt of HealtheRx

Exclusion Criteria:

-

Related Conditions & MeSH terms

• Asthma
• COPD

Intervention

Other:
• HealtheRx+
Participant receives $5 bill with incentive check and blank consent form
• HealtheRx++
Participant receives $5 bill when they returned signed PRR consent form.

Locations

Country	Name	City	State
United States	University of Chicago	Chicago	Illinois

Sponsors (1)

Lead Sponsor	Collaborator
University of Chicago

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Other	Proportion of individuals who consent		6 months
Other	Mean days to consent		6 months
Primary	Cost per consented subject		6 months
Secondary	Mean number of consented subjects per week		6 months